LeMaitre to Present at Upcoming Investor Conferences in August
Monday, July 31, 2023 1 min read
Key Takeaway: LeMaitre Vascular, Inc. is set to participate in two investor conferences in August 2023, showcasing its commitment to stakeholder engagement. CFO JJ Pellegrino will attend the Needham Virtual MedTech & Diagnostics 1x1 Conference, while President David Roberts will present at the UBS MedTech, Tools and Genomics Summit. This engagement underscores the company's positioning as a key player in the vascular device industry, addressing peripheral vascular diseases affecting millions globally.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in investor conferences indicates robust engagement.
Leadership representation at major industry events highlights confidence.
Focus on vascular disease treatment aligns with significant global health needs.
Full Press Release Details
BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in August.
JJ Pellegrino, Chief Financial Officer, will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023.
David Roberts, President, will present at the UBS MedTech, Tools and Genomics Summit at the Waldorf Astoria in Dana Point, CA. The company’s presentation is scheduled at 1:00 PM PT (4:00 PM ET).
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.